Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
17.21 USD | +2.99% | +7.90% | -9.90% |
08/05 | Transcript : Arcus Biosciences, Inc., Q1 2024 Earnings Call, May 08, 2024 | |
08/05 | Earnings Flash (RCUS) ARCUS BIOSCIENCES Posts Q1 Revenue $145M | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-9.90% | 1.52B | |
+26.37% | 44.96B | |
-1.01% | 42.65B | |
+46.00% | 41.85B | |
-5.31% | 29.04B | |
+9.34% | 26.08B | |
-21.69% | 19.03B | |
+6.23% | 12.75B | |
+26.99% | 12.06B | |
-3.38% | 11.75B |
- Stock Market
- Equities
- RCUS Stock
- News Arcus Biosciences, Inc.
- Cantor Fitzgerald Adjusts Arcus Biosciences' Price Target to $36 From $46, Maintains Overweight Rating